✦ LIBER ✦

The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery

✍ Scribed by Andreas Wedrich; Rupert Menapace; Eva Mühlbauer-Ries

Publisher: Springer Netherlands
Year: 1995
Tongue: English
Weight: 353 KB
Volume: 18
Category: Article
ISSN: 0165-5701
DOI: 10.1007/bf00917830

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of tissue plasminogen activator for

Use of tissue plasminogen activator for rapid dissolution of fibrin and blood clots in the eye after surgery for glaucoma and cataract in humans

✍ Ramesh C. Tripathi; Brenda J. Tripathi; Scott Bornstein; Eugene Gabianelli; J. T 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Characterization of indium-111 labeled r

Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi

✍ D. J. Hnatowich; F. Virzi; P. W. Doherty; J. Wilson; J. Rosa; J. E. Ansell 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 708 KB

The in vitro functional properties of recombinant tissue plasminogen activator (rt-PA), its biodistribution in mice, and its pharmacokinetics and clot localization properties in dogs have been investigated after labeling rt-PA with 111In. The rt-PA was coupled with the bicyclic anhydride of DTPA usi

Intravesical recombinant tissue plasmino

Intravesical recombinant tissue plasminogen activator for the prevention of implantation-mediated bladder tumor recurrence

✍ William A. See 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 941 KB

The mechanism by which intravesical recombinant tissue plasminogen activator (rTPA) prevents tumor cell adherence to injured bladder surfaces, and the optimal parameters for the in vivo use of rTPA for adherence prevention, were evaluated. Intravesical rTPA decreased tumor cell adherence to sites of

The use of free flow electrophoresis in

The use of free flow electrophoresis in the purification of recombinant human tissue plasminogen activator expressed in yeast

✍ Françoise Barth; Dr. Markus G. Gruetter; Reinhard Kessler; Hans-Jörg Manz 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

The determination of recombinant human t

The determination of recombinant human tissue-type plasminogen activator activity by turbidimetry using a microcentrifugal analyzer

✍ Ronald H. Carlson; Robert L. Garnick; Andrew J.S. Jones; Ann M. Meunier 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 668 KB

A method is described for determining the activity of recombinant human tissue-type plasminogen activator (rt-PA) by turbidimetry using a microcentrifugal analyzer (MCA). A mixture of thrombin and rt-PA is centrifuged into a mixture of fibrinogen and plasminogen to initiate clot formation and subseq

Microvascular repair following a modifie

Microvascular repair following a modified crush-avulsion injury in a rat model: Effect of recombinant human tissue-type plasminogen activator on the patency rate

✍ Efstathios G. Lykoudis; Petros N. Panayotou; Constantinos N. Stamatopoulos; Kons 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

The failure rate of replantations following a crush-avulsion type injury is high. This study has been designed to reproduce an effective standardized crush-avulsion injury model to the femoral artery of the rat and evaluate the antithrombotic efficacy of systemic intravenous administration of recomb